Jump to full article: Gulf News (ae), 2008-04-01
Author: Nina Muslim, Staff Reporter
Intro: People in the UAE and other Middle Eastern countries are developing lung disease at a younger age and the trend is set to worsen, researchers warned.
The 46-country Greatest International Antibiotic Trial (Giant) studied the prevalence of acute exacerbate chronic bronchitis (AECB), a form of lung disease, and the effectiveness of Bayer Schering Pharma's antibiotic in treating it.
It found a majority of the 4,300 subjects in the Middle East were reporting the disease at 48.5 years old, the youngest compared to other regions.
The average age for lung disease in Latin America was 63.1 years, followed by Europe at 60.5 and Asia-Pacific with 57.1 years.
. . .
He warned the outlook in the Middle East was grim: "What is happening here is what has happened in the US and Europe 20 years ago. There are more women smokers [and] it's going to get worse if nothing changes."
Jump to full article » |